Forkhead-box A1 (FOXA1) expression in breast cancer and its prognostic significance

被引:92
作者
Habashy, Hany Onsy [1 ,4 ]
Powe, Desmond G. [1 ]
Rakha, Emad A. [1 ]
Ball, Graham [2 ]
Paish, Claire [1 ]
Gee, Julia [3 ]
Nicholson, Robert I. [3 ]
Ellis, Ian O. [1 ]
机构
[1] Univ Nottingham, Sch Mol Med Sci, Dept Histopathol, Nottingham Univ Hosp NHS Trust, Nottingham, England
[2] Nottingham Trent Univ, Div Life Sci, Nottingham, England
[3] Cardiff Univ, Welsh Sch Pharm, Cardiff, S Glam, Wales
[4] Mansoura Univ, Fac Med, Dept Histopathol, Mansoura, Egypt
关键词
breast carcinoma; FOXA1; oestrogen receptor; prognosis;
D O I
10.1016/j.ejca.2008.04.020
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The forkhead-box A1 (FOXA1) controls downstream transcription of oestrogen receptor (ER)-regulated genes. In this study, the biological and prognostic value of FOXA1 expression was assessed immunohistochemically in a large and well-characterised series of invasive breast carcinoma with a long term follow-up using tissue microarray. FOXA1 expression was associated with steroid hormone receptors (ER alpha, PgR and AR), other variables of good prognosis such as smaller tumour size, lower histological grade, luminal cytokeratins (CK18 and CK7/8), BRCA1 and E-cadherin. Its expression showed an inverse relation with basal CKs (CK14 and CK5/6) and P-cadherin. We found an association between high FOXA1 expression and a better survival in the whole series however; multivariate analysis showed that FOXA1 was not an independent prognostic marker. In conclusion, our results show that FOXA1 protein is associated with markers of good prognosis supporting its role as a growth repressor in breast cancer. In this series, FOXA1 was found not to be of an independent prognostic significance in breast cancer and as such its immunohistochemical assessment alone does not appear to have relevance in routine practice to stratify ER-positive (luminal-like) tumours into clinically significant subgroups. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1541 / 1551
页数:11
相关论文
共 25 条
[1]   High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses [J].
Abd El-Rehim, DM ;
Ball, G ;
Pinder, SE ;
Rakha, E ;
Paish, C ;
Robertson, JFR ;
Macmillan, D ;
Blamey, RW ;
Ellis, IO .
INTERNATIONAL JOURNAL OF CANCER, 2005, 116 (03) :340-350
[2]  
Abdel-Fatah T, 2007, VIRCHOWS ARCH, V451, P143
[3]   FOXA1 expression in breast cancer - Correlation with luminal subtype A and survival [J].
Badve, Sunil ;
Turbin, Dmitry ;
Thorat, Mangesh A. ;
Morimiya, Akira ;
Nielsen, Torsten O. ;
Perou, Charles M. ;
Dunn, Sandi ;
Huntsman, David G. ;
Nakshatri, Harikrishna .
CLINICAL CANCER RESEARCH, 2007, 13 (15) :4415-4421
[4]   Estrogen receptor target gene: An evolving concept [J].
Carroll, Jason S. ;
Brown, Myles .
MOLECULAR ENDOCRINOLOGY, 2006, 20 (08) :1707-1714
[5]   Expression of luminal and basal cytokeratins in human breast carcinoma [J].
El-Rehim, DMA ;
Pinder, SE ;
Paish, CE ;
Bell, J ;
Blamey, R ;
Robertson, JFR ;
Nicholson, RI ;
Ellis, IO .
JOURNAL OF PATHOLOGY, 2004, 203 (02) :661-671
[6]   PATHOLOGICAL PROGNOSTIC FACTORS IN BREAST-CANCER .1. THE VALUE OF HISTOLOGICAL GRADE IN BREAST-CANCER - EXPERIENCE FROM A LARGE STUDY WITH LONG-TERM FOLLOW-UP [J].
ELSTON, CW ;
ELLIS, IO .
HISTOPATHOLOGY, 1991, 19 (05) :403-410
[7]   THE NOTTINGHAM PROGNOSTIC INDEX IN PRIMARY BREAST-CANCER [J].
GALEA, MH ;
BLAMEY, RW ;
ELSTON, CE ;
ELLIS, IO .
BREAST CANCER RESEARCH AND TREATMENT, 1992, 22 (03) :207-219
[8]   Location analysis of estrogen receptor α target promoters reveals that FOXA1 defines a domain of the estrogen response [J].
Laganière, J ;
Deblois, G ;
Lefebvre, C ;
Bataille, AR ;
Robert, F ;
Giguère, V .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (33) :11651-11656
[9]  
Lin L, 2002, CANCER RES, V62, P5273
[10]   Regulatory mechanisms controlling human E-cadherin gene expression [J].
Liu, YN ;
Lee, WW ;
Wang, CY ;
Chao, TH ;
Chen, Y ;
Chen, JH .
ONCOGENE, 2005, 24 (56) :8277-8290